Dosar de subiect

Sanatate

Aprobat in SUA un nou medicament oral pentru pierderea in greutate

Primul articol: 1 apr. 2026, 21:54 | Ultima actualizare: 1 apr. 2026, 21:54 | 1 sursa | 1 articol
#obezitate#medicament#elililly

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

Un nou medicament oral pentru pierderea in greutate, dezvoltat de compania farmaceutica Eli Lilly, a fost aprobat in Statele Unite. Acest medicament ofera o alternativa potentiala pentru persoanele care se lupta cu obezitatea si pot avea dificultati in a pierde in greutate prin dieta si exercitii fizice. Aprobarea acestui medicament ar putea avea un impact semnificativ asupra tratamentului obezitatii.

Articole despre acest subiect

US approves new oral weight-loss pill developed by Eli Lilly Foto: The Guardian
The Guardian English Marina Dunbar 1 apr. 2026, 21:54 (acum 2 ore)

US approves new oral weight-loss pill developed by Eli Lilly

Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s WegovyThe US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received approv

Citeste pe The Guardian →